Sports Medicine

, Volume 6, Issue 6, pp 364–377 | Cite as

Effects of Exercise on Atrial Natriuretic Factor

Release Mechanisms and Implications for Fluid Homeostasis
  • Beau J. Freund
  • Charles E. Wade
  • John R. Claybaugh
Research Review

Summary

Atrial natriuretic factor is reported to be elevated during and immediately following exercise and is thought to play a role in fluid homeostasis and cardiovascular regulation. The predominant stimuli for atrial natriuretic factor release during exercise appear to be increases in atrial pressures or atrial distension, both of which are reported to increase with exercise. The intensity and perhaps duration of exercise also influence the magnitude of the atrial natriuretic factor response. It is not clear if the rise in plasma atrial natriuretic factor during exercise plays any role in altering renal function since high intensity exercise is typically associated with an antidiuresis. However, elevations in plasma atrial natriuretic factor may in part be responsible for the increase in urine flow reported when exercise is performed at low or moderate intensities. Atrial natriuretic factor also has vascular effects which may be important in buffering or moderating the blood pressure response to exercise.

The atrial natriuretic factor response to exercise and basal levels of the hormone are greatly elevated in patients who suffer from a variety of cardiovascular and pulmonary disease conditions. These elevated plasma atrial natriuretic factor values are associated with increases in atrial pressure and appear to be related to the severity of disease. Although much controversy exists regarding the renal and vascular effects of atrial natriuretic factor, the measurement of this hormone, particularly during exercise, may be of clinical value by providing an additional tool to evaluate patients and determine the effectiveness of various treatment regimens.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adnot S, Chabrier PE, Andrivet P, Viossat I, Piquet J, et al. Atrial natriuretic peptide concentrations and pulmonary hemodynamics in patients with pulmonary artery hypertension. American Reviews in Respiratory Disease 136: 951–956, 1987CrossRefGoogle Scholar
  2. Anderson JV, Miller ND, O’Hare JP, Mackenzie JC, Corrall RJM, et al. Atrial natriuretic peptide: physiological release associated with natriuresis during water immersion in man. Clinical Science 70: 507–512, 1986aPubMedGoogle Scholar
  3. Anderson JV, Raine AEG, Proudler A, Bloom SR. Effect of haemodialysis on plasma concentrations of atrial natriuretic peptide in adult patients with chronic renal failure. Journal of Endocrinology 110: 193–196, 1986bPubMedCrossRefGoogle Scholar
  4. Aurell M, Carlsson M, Grimby G, Hood B. Plasma concentration and urinary excretion of certain electrolytes during supine work. Journal of Applied Physiology 22: 633–638, 1967PubMedGoogle Scholar
  5. Bates ER, Shenker Y, Grekin RJ. The relationship between plasma levels of immunoreactive atrial natriuretic factor. Hypertension 4: S13–S16, 1986CrossRefGoogle Scholar
  6. Bie P, Wang BC, Leadley Jr RJ, Goetz KL. Haemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs. American Journal of Physiology 254: R161–R169, 1988PubMedGoogle Scholar
  7. Boening J, Skipka W. Renal blood volume regulation in trained and untrained subjects during immersion. European Journal of Applied Physiology and Occupational Physiology 42: 247–254, 1979CrossRefGoogle Scholar
  8. Bolli P, Muller FB, Linder L, Raine AEG, Resink TJ, et al. The vasodilator potency of atrial natriuretic peptide in man. Circulation 75: 221–228, 1987PubMedCrossRefGoogle Scholar
  9. Bussien JP, Biollaz J, Waeber B, Nussberger J, Turini GA, et al. Dose-dependent effect of atrial natriuretic peptide on blood pressure, heart rate, and skin blood flow of normal volunteers. Journal of Cardiovascular Pharmacology 8: 216–220, 1986PubMedCrossRefGoogle Scholar
  10. Casterfors J, Mossfeldt F, Piscator M. Effect of prolonged heavy exercise on renal function and urinary protein excretion. Acta Physiologica Scandinavica 70: 194–206, 1967CrossRefGoogle Scholar
  11. Chatterjee K, Rubin SA, Ports TA, Parmley WW. Influence of oral prazosin therapy on exercise haemodynamics in patients with severe chronic heart failure. American Journal of Medicine 71: 140–146, 1981PubMedCrossRefGoogle Scholar
  12. Claybaugh JR, Pendergast DR, Davis JE, Akiba C, Pazik M, et al. Fluid conservation in athletes: responses to water intake, supine posture and immersion. Journal of Applied Physiology 61: 7–15, 1986PubMedGoogle Scholar
  13. Cogan E, Debieve M, Pepersack T, Abramow M. High plasma levels of atrial natriuretic factor in SIADH. New England Journal of Medicine 314: 1258–1259, 1986PubMedCrossRefGoogle Scholar
  14. Convertino VA, Brock PJ, Keil LC, Bernauer EM, Greenleaf JE. Exercise training-induced hypervolemia: role of plasma albumin, renin, and vasopressin. Journal of Applied Physiology 48: 665–669, 1980PubMedGoogle Scholar
  15. Crandall ME, Gregg CM. In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release. Neuroendocrinology 44: 439–445, 1986PubMedCrossRefGoogle Scholar
  16. Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Joyce SL, et al. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. Journal of Clinical Endocrinology and Metabolism 63: 946–953, 1986PubMedCrossRefGoogle Scholar
  17. Currie MG, Newman WH. Evidence for α1-adrenergic receptor regulation of atriopeptin release from isolated rat heart. Biochemical and Biophysical Research Communications 137: 94–107, 1986PubMedCrossRefGoogle Scholar
  18. de Bold AJ, Borenstein HB, Veress AT, Sonenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Science 28: 89–94, 1981CrossRefGoogle Scholar
  19. Dietz R, Lang RE, Purgaj J, Merkel A, Schomig A, et al. Relationships between haemodynamic parameters and concentrations of atrial natriuretic peptide in human plasma. Journal of Hypertension 4(Suppl. 6): S512–S515, 1986aPubMedGoogle Scholar
  20. Dietz R, Purgaj J, Lang RE, Schomig A. Pressure dependent release of atrial natriuretic peptide (ANP) in patients with chronic cardiac diseases: does it reset? Klinische Wochenschrift 64(Suppl. VI): 42–46, 1986bPubMedGoogle Scholar
  21. Donckier JE, Anderson JV, Bloom SR. Alpha-atrial natriuretic peptide concentrations in plasma in children with congenital heart and pulmonary diseases. British Medical Journal 291: 1648, 1985PubMedCrossRefGoogle Scholar
  22. Emmick JT, Cohen ML. Aging and vasodilation to atrial peptides. Clinical and Experimental Theory and Practice A8(1): 75–90, 1986Google Scholar
  23. Espiner EA, Nicholls MG, Yandle TG, Crozier IG, Cuneo RC, et al. Studies on the secretion, metabolism and action of atrial natriuretic peptide in man. Journal of Hypertension 4(Suppl. 2): S85–S91, 1986PubMedGoogle Scholar
  24. Freund BJ, Claybaugh JR, Dice MS, Hashiro GM. Hormonal and vascular fluid responses to maximal exercise in trained and untrained males. Journal of Applied Physiology 63: 669–675, 1987aPubMedGoogle Scholar
  25. Freund BJ, Claybaugh JR, Hashiro GM, Dice MS. Hormonal and renal responses to water drinking in moderately trained and untrained humans. American Journal of Physiology 254 (Regulatory, Integrative and Comparative Physiology): R417–R423, 1988aPubMedGoogle Scholar
  26. Freund BJ, Claybaugh JR, Hashiro GM, Wortham DC. Hormonal and renal responses to a reduction in plasma osmolality: further evidence of a water conservation in endurance trained men. (Abstract.) Federation Proceedings 2: A1484, 1988bGoogle Scholar
  27. Freund B, Hashiro G, Buono M, Claybaugh J, Chrisney S. Endocrine and electrolyte responses during and following a marathon in young versus middle aged runners. (Abstract.) Medicine and Science in Sports and Exercise, in press, 1988cGoogle Scholar
  28. Freund BJ, Joyner MJ, Jilka SM, Kalis J, Nittolo JM, et al. Thermoregulation during prolonged exercise in heat: alterations with beta-adrenergic blockade. Journal of Applied Physiology 63: 930–936, 1987bPubMedGoogle Scholar
  29. Fujio N, Ohashi M, Nawata H, Kato K, Ibyashi H, et al. Human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects. Clinical Endocrinology 25: 181–187, 1986PubMedCrossRefGoogle Scholar
  30. Fyhrquist F, Tikkanen I, Totterman KJ, Hynynen M, Tikkanen T, et al. Plasma atrial natriuretic peptide in health and disease. European Heart Journal 8(Suppl. B): 117–122, 1987PubMedCrossRefGoogle Scholar
  31. Gerbes AL, Arendt RM, Schnizer W, Silz S, Jungst D, et al. Regulation of atrial natriuretic factor release in man: effect of water immersion. Klinische Wochenschrift 64: R638–R643, 1986CrossRefGoogle Scholar
  32. Goetz KL. Physiology and pathophysiology of atrial peptides. American Journal of Physiology 254 (Endocrinology and Metabolism): E1–E15, 1988PubMedGoogle Scholar
  33. Guyton A. Venous return. In Hamilton & Dow (Eds) Handbook of Physiology, Vol. 2, pp. 1099–1113, American Physiological Society, Washington D.C., 1963Google Scholar
  34. Harrison MH. Effect of thermal stress and exercise on blood volume in humans. Physiological Reviews 65: 149–209, 1985PubMedGoogle Scholar
  35. Hodsman GP, Phillips PA, Ogawa K, Johnston CI. Atrial natriuretic factor in normal man: effects of tilt, posture, exercise and haemorrhage. Journal of Hypertension 4(Suppl. 6): S503–S505, 1986PubMedGoogle Scholar
  36. Kachadorian WA, Johnson RE. Renal responses to various rates of exercise. Journal of Applied Physiology 28: 748–752, 1970PubMedGoogle Scholar
  37. Kangawa K, Matsuo H. Purification and complete amino acid sequence of alpha-human atrial natriuretic polypeptide. Biochemical and Biophysical Research Communications 118: 131–139, 1984PubMedCrossRefGoogle Scholar
  38. Keller N, Larsen J, Sykulski R, Strom T, Thamsborg G. Atrial natriuretic factor during exercise in patients with congestive heart failure. Acta Endocrinologica 118: 168–172, 1988PubMedGoogle Scholar
  39. Keller N, Miller T, Sykulski R, Storm TL, Thamsborg GM. Effect of alpha-1 adrenoceptor blockade on plasma levels of atrial natriuretic peptide during dynamic exercise in normal man. Hormonal and Metabolism Research 19: 334, 1987Google Scholar
  40. Lijnen P, Hespel P, M’Buyamba-Kabangu JR, Goris M, Lysens R, et al. Plasma atrial natriuretic polypeptide and cyclic nucleotide levels before and after a marathon. Journal of Applied Physiology 63: 1180–1184, 1987PubMedGoogle Scholar
  41. Manning PT, Schartz D, Katsube NC, Holmberg SW, Needleman P. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science 229: 395–400, 1985PubMedCrossRefGoogle Scholar
  42. Matsubara H, Nishikawa M, Umeda Y, Taniguchi T, Iwasaka T, et al. The role of atrial pressure in secreting atrial natriuretic polypeptides. American Heart Journal 113: 1457–1463, 1987PubMedCrossRefGoogle Scholar
  43. Morris M, Cain M, Russell A, Elliott J, Chalmers J. Direct radioimmunoassay of human plasma atrial natriuretic peptide in various normal and pathophysiological states: increase in renal and cardiac failure during exercise. Clinical and Experimental Theory and Practice A9(4): 703–718, 1987Google Scholar
  44. Muller FB, Erne P, Raine AE, Bolli P, Linder L, et al. Atrial antipressor natriuretic peptide: release mechanisms and vascular actions in man. Journal of Hypertension 4(Suppl. 2): S109–S114, 1986PubMedGoogle Scholar
  45. Nicklas JM, DiCarlo LA, Koller PT, Morady F, Diltz EA, et al. Plasma levels of immunoreactive atrial natriuretic factor increases during supraventricular tachycardia. American Heart Journal 112: 923–928, 1986PubMedCrossRefGoogle Scholar
  46. Nishikimi T, Kohno M, Matsuura T, Akioka K, Teragaki M, et al. Effect of exercise on circulating atrial naturetic polypeptide in valvular heart disease. American Journal of Cardiology 58: 1119–1120, 1986aPubMedCrossRefGoogle Scholar
  47. Nishikimi T, Kohno M, Matsuura T, Kanayama Y, Akioka K, et al. Circulating atrial natriuretic polypeptide during exercise in patients with essential hypertension. Journal of Hypertension 4(Suppl. 16): S546–S549, 1986bPubMedGoogle Scholar
  48. Ogawa K, Smith AI, Hodsman GP, Jackson B, Woodcock EA, et al. Plasma atrial natriuretic peptide: concentrations and circulating forms in normal man and patients with chronic renal failure. Clinical and Experimental Pharmacology and Physiology 14: 95–102, 1987PubMedCrossRefGoogle Scholar
  49. Ohashi M, Fujio N, Nawata H, Kato K, Ibayashi H, et al. High plasma concentration of human atrial natriuretic polypeptide in aged men. Journal of Clinical Endocrinology and Metabolism 64: 81–85, 1987PubMedCrossRefGoogle Scholar
  50. Petzl DH, Hartter E, Osterode W, Bohm H, Wologzczuk W. Atrial natriuretic peptide release due to physical exercise in healthy persons and in cardiac patients. Klinische Wochenschrift 65: 194–196, 1987PubMedCrossRefGoogle Scholar
  51. Raine AE, Erne P, Burgisser E, Muller FB, Bolli P, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. New England Journal of Medicine 315: 533–537, 1986PubMedCrossRefGoogle Scholar
  52. Rankin AJ, Wilson N, Ledsome JR. Effects of autonomic stimulation on plasma immunoreactive atrial natriuretic peptide in the anesthetised rabbit. Canadian Journal of Physiology and Pharmacology 65: 532–537, 1987PubMedCrossRefGoogle Scholar
  53. Richards AM, Tonolo G, Cleland JG, McIntyre GD, Leckie BJ, et al. Plasma atrial natriuretic peptide concentrations during exercise in sodium repleted and depleted normal man. Clinical Science 72: 159–164, 1987PubMedGoogle Scholar
  54. Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiological Reviews 54: 75–159, 1974PubMedGoogle Scholar
  55. Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Raised circulating levels of atrial natriuretic peptide in essential hypertension. Lancet 1: 179–181, 1986PubMedCrossRefGoogle Scholar
  56. Saito Y, Nakao K, Sugawara A, Nishimura K, Sakamoto M. Atrial natriuretic polypeptide during exercise in healthy man. Acta Endocrinologica 116: 59–65, 1987PubMedGoogle Scholar
  57. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40: 227–279, 1985Google Scholar
  58. Sanfield JA, Shenker Y, Grekin RJ, Rosen SG. Epinephrine increases plasma immunoreactive atrial natriuretic hormone levels in humans. American Journal of Physiology 252: E740–E745, 1987PubMedGoogle Scholar
  59. Schiflfrin EL, Gutkowska J, Kuchel O, Cantin M, Genest J. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal tachycardia. New England Journal of Medicine 312: 1196, 1985CrossRefGoogle Scholar
  60. Skipka W, Boening D, Deck KA, Kulpmann WR, Meurer A. Reduced aldosterone and sodium excretion in endurance-trained athletes before and during immersion. European Journal of Applied Physiology and Occupational Physiology 42: 255–261, 1979PubMedCrossRefGoogle Scholar
  61. Somers VK, Anderson JV, Conway J, Sleight P, Bloom SR. Atrial natriuretic peptide is released by dynamic exercise in man. Hormonal Metabolism and Research 18: 871–872, 1986CrossRefGoogle Scholar
  62. Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JR Relationship between renal haemodynamic and natriuretic effects of atrial natriuretic factor. American Journal of Physiology 250: F520–F524, 1988Google Scholar
  63. Sugawara A, Nakao K, Sakamoto M, Morii N, Yamada T, et al. Plasma concentrations of atrial natriuretic polypeptide in essential hypertension. Lancet 2: 1426–1427, 1985PubMedCrossRefGoogle Scholar
  64. Tajima H, Sagawa S, Iwamoto J, Miki K, Claybaugh JR, et al. Cardiovascular and endocrine responses in the elderly during head-out water immersion. American Journal of Physiology, in press, 1988Google Scholar
  65. Tanaka H, Shindo M, Gutkowska J, Kinoshita A, Urata H, et al. Effect of acute exercise on plasma immunoreactive-atrial natriuretic factor. Life Science 39: 1685–1693, 1986CrossRefGoogle Scholar
  66. Thamsborg G, Storm T, Keller N, Sykulski R, Larsen J. Changes in plasma atrial natriuretic peptide during exercise in healthy volunteers. Acta Medica Scandinavia 221: 441–444, 1987aCrossRefGoogle Scholar
  67. Thamsborg G, Sykulski R, Larsen J, Storm J, Keller N. Effect of beta 1-adrenoceptor blockade on plasma levels of atrial natriuretic peptide during exercise in normal man. Clinical Physiology 7: 313–318, 1987bPubMedCrossRefGoogle Scholar
  68. Tikkanen I, Metsarinne K, Fyhrquist F. Atrial natriuretic peptide in polyuria associated with paroxysmal supraventricular tachycardia. Lancet 2: 40–41, 1987Google Scholar
  69. Toshiro O, Shima J, Hara H, Kumahara Y, Kang K, et al. Changes in human plasma atrial natriuretic polypeptide concentration in normal subjects during passive leg raising and whole-body tilting. Clinical Science 71: 147–150, 1986Google Scholar
  70. Tunny TJ, Higgins BA, Gordon RD. Plasma levels of atrial natriuretic peptide in primary aldosteronism, in Gordon’s syndrome and in Batter’s syndrome. Clinical and Experimental Pharmacology and Physiology 13: 341–345, 1986PubMedCrossRefGoogle Scholar
  71. Virvidakis C, Loukas A, Mayopoulou-Symvoulidou D, Mountokalakis T. Renal responses to bicycle exercise in trained athletes: influence of exercise intensity. International Journal of Sports Medicine 7: 86–88, 1986PubMedCrossRefGoogle Scholar
  72. Wade CE. Response, regulation, and actions of vasopressin during exercise: a review. Medicine and Science in Sports and Exercise 16: 506–511, 1984PubMedCrossRefGoogle Scholar
  73. Wade CE, Claybaugh JR. Plasma renin activity, vasopressin concentration, and urinary excretory responses to exercise in man. Journal of Applied Physiology 49: 930–936, 1980PubMedGoogle Scholar
  74. Walker GR, Swainson CP, Yandle TG, Nicholls MG, Espiner EA. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure. Clinical Science 72: 19–24, 1987PubMedGoogle Scholar
  75. Walsh KP, Williams TDM, Pitts SE, Lightman SL, Sutton R. Role of atrial pressure and rate release of atrial natriuretic peptide. American Journal of Physiology 254: R607–R610, 1988PubMedGoogle Scholar
  76. Weidmann P, Hasler L, Gnadinger MP, Lang RE, Uehlinger DE, et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. Journal of Clinical Investigation 77: 734–742, 1986PubMedCrossRefGoogle Scholar
  77. Yamaji T, Ishibashi M, Nakaoka H, Imataka K, Amano M, et al. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias. Lancet 1: 1211, 1985PubMedCrossRefGoogle Scholar
  78. Zimmerman RS, Edwards BS, Schwab TR, Heublein DM, Burnett IC. Cardiorenal-endocrine dynamics during and following volume expansion. American Journal of Physiology 252: R336–R340, 1987PubMedGoogle Scholar

Copyright information

© ADIS Press Limited 1988

Authors and Affiliations

  • Beau J. Freund
    • 1
    • 2
  • Charles E. Wade
    • 1
    • 2
  • John R. Claybaugh
    • 1
    • 2
  1. 1.Department of Clinical InvestigationTripler Army Medical Center, TAMCHonoluluUSA
  2. 2.Division of Combat Casualty CareLetterman Army Institute of ResearchSan FranciscoUSA

Personalised recommendations